Ramiro Sanchez - 07 Nov 2024 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
RAPP
Transactions as of
07 Nov 2024
Transactions value $
$0
Form type
4
Filing time
07 Nov 2024, 18:47:12 UTC
Previous filing
05 Aug 2024
Next filing
18 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPP Stock Option (Right to Buy) Award $0 +29.8K $0.00 29.8K 07 Nov 2024 Common Stock 29.8K $26.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares underlying this option shall vest and become exercisable on November 7, 2025, with the remaining shares vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.